PerkinElmer to acquire Caliper Life Sciences
PerkinElmer has recently signed an agreement to acquire Caliper Life Sciences Inc., (Hopkinton, Massachusetts), a leader in imaging and detection solutions for life sciences, research, diagnostics and environmental markets .
PerkinElmer has recently signed an agreement to acquire Caliper Life Sciences Inc., (Hopkinton, Massachusetts), a leader in imaging and detection solutions for life sciences, research, diagnostics and environmental markets for a total net purchase price of approximately $600 million in cash.
Commenting on the acquisition, Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, “The R&D, application expertise and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of innovation. Additionally, the proven leadership and talent of the Caliper team will be a strong addition to our organization.”
As a result of the agreement, the company will be able to provide a number of additional services including further scope for molecular, cellular, animal and tissue imaging to enable translational medicine research; high-value sample preparation technologies for key scientific workflow areas such as next generation DNA sequencing and expansion into areas such as the detection of environmental contaminants and food pathogens.
Kevin Hrusovsky, chief executive officer, Caliper Life Sciences expressed his delight at becoming part of PerkinElmer and the opportunities that this will open up for making advances into improving human and environmental health.
For more information visit www.perkinelmer.com
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
